Turnstone Biologics Corp. (TSBX) Misses Q2 EPS by 455c

Turnstone Biologics Corp. (NASDAQ: TSBX) reported Q2 EPS of ($7.56), $4.55 worse than the analyst estimate of ($3.01).

For earnings history and earnings-related data on Turnstone Biologics Corp. (TSBX) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Hooker Furniture (HOFT) Tops Q2 EPS by 16c, Misses on Revenue
• Premarket movers: Oracle surges on AI growth, ACV auctions jumps on $1.9B deal